Naomi De Silva
- Genetics top 5%
- Oncology top 10%
- Molecular Biology
- Immunology
- Biotechnology top 5%
- Co-authors
- John C. BellDavid H. KirnCaroline J. BreitbachManijeh DaneshmandTae-Ho HwangAnne MoonJames M. BurkeJean‐Simon Diallo
- Topics
- Virus-based gene therapy research (9 papers)CAR-T cell therapy research (7 papers)Viral Infectious Diseases and Gene Expression in Insects (4 papers)
- Cited by
- GeneticsOncologyBiotechnology
- Partner nations
- CanadaUnited StatesSouth Korea
In The Last Decade
Naomi De Silva
10 papers receiving 510 citations
Peers
Comparison fields: 5 of 33
- Genetics 431
- Oncology 357
- Molecular Biology 198
- Immunology 122
- Biotechnology 110
Countries citing papers authored by Naomi De Silva
This map shows the geographic impact of Naomi De Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi De Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi De Silva more than expected).
Fields of papers citing papers by Naomi De Silva
This network shows the impact of papers produced by Naomi De Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi De Silva. The network helps show where Naomi De Silva may publish in the future.
Co-authorship network of co-authors of Naomi De Silva
This figure shows the co-authorship network connecting the top 25 collaborators of Naomi De Silva. A scholar is included among the top collaborators of Naomi De Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi De Silva. Naomi De Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 1 | |
| 3 | 55 | |
| 4 | 208 | |
| 5 | 17 | |
| 6 | 1 | |
| 7 | 18 | |
| 8 | 122 | |
| 9 | 27 | |
| 10 | 60 |
About Naomi De Silva
Naomi De Silva is a scholar working on Biotechnology, Genetics and Oncology, having authored 10 papers that have together received 520 indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). The work is most often cited by research in Genetics (431 citations), Oncology (357 citations) and Biotechnology (110 citations). Naomi De Silva has collaborated with scholars based in Canada, United States and South Korea. Frequent co-authors include John C. Bell, David H. Kirn, Caroline J. Breitbach, Manijeh Daneshmand, Tae-Ho Hwang, Anne Moon, James M. Burke, Jean‐Simon Diallo, Rozanne Arulanandam and Jeong Heo. Their work appears in journals such as PLoS ONE, Cancer Research and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.